Payments to Acquire Property, Plant, and Equipment of ELITE PHARMACEUTICALS INC /NV/ from 31 Mar 2022 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
ELITE PHARMACEUTICALS INC /NV/ quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2022 to 30 Jun 2025.
  • ELITE PHARMACEUTICALS INC /NV/ Payments to Acquire Property, Plant, and Equipment for the quarter ending 30 Jun 2025 was $218,204, a 72% decline year-over-year.
  • ELITE PHARMACEUTICALS INC /NV/ annual Payments to Acquire Property, Plant, and Equipment for 2024 was $1,625,082, a 101% increase from 2023.
  • ELITE PHARMACEUTICALS INC /NV/ annual Payments to Acquire Property, Plant, and Equipment for 2023 was $809,653, a 86% decline from 2022.
  • ELITE PHARMACEUTICALS INC /NV/ annual Payments to Acquire Property, Plant, and Equipment for 2022 was $5,736,618, a 1051% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

ELITE PHARMACEUTICALS INC /NV/ Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $218,204 -$560,323 -72% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q2 2024 $778,527 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2026 Q1
Q2 2022 $94,597 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2024 Q1

ELITE PHARMACEUTICALS INC /NV/ Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,625,082 +$815,429 +101% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2025 FY
2023 $809,653 -$4,926,965 -86% 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025 2025 FY
2022 $5,736,618 +$5,238,052 +1051% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024 2024 FY
2021 $498,566 01 Apr 2021 31 Mar 2022 10-K 29 Jun 2023 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.